Tailored Patient-centric Solutions to Maximize Clinical Trial Recruitment & Retention
The Patient Pathway to Better Clinical Trial Recruitment & Retention
Allucent’s Patient Engagement Group utilizes a patient pathway methodology to ensure smarter patient recruitment, stronger engagement, and more inclusive participation across all trial designs from traditional on-site to fully decentralized models.
Through a combination of in-house expertise, strategic site partnerships, tech-enabled solutions, and IGNITE™, our global site network of pre‑qualified therapeutically aligned research sites, we deliver agile, scalable strategies that accelerate patient recruitment from first-patient-in (FPI) through to the last patient enrolled and improve retention by supporting successful trial execution from start to finish.
Comprehensive Patient Recruitment & Retention Services
- Global reach with high-performing site access across key geographies
- IGNITE™ site network accelerates site activation and study start-up
- Data-driven site and patient identification for predictable enrollment
- Patient-focused communications that strengthen recruitment and retention
- PAG and community engagement to enhance participation and support
- Travel and concierge support to remove barriers to trial participation

Clinical Trial Site Support
Sites are the cornerstone of successful patient recruitment and retention, and our sites enhance efficiency, reach, and quality.

Special Patient Populations
Ensuring diversity and access to special patient populations for clinical trial participation is essential as people of different ages, races, ethnicities, genders, socioeconomic backgrounds, geographic locations, and disease characteristics may experience treatments differently.

Patient Advocacy Group (PAG) Engagement & Recruitment Support
Patient advocacy groups can be instrumental in bridging the gap between clinical researchers and participants.

Patient Engagement & Education
Educated patients are more likely to stay engaged and less likely to drop out if they have realistic expectations of processes and outcomes.

Digital Patient Recruitment & Outreach
Digital technology plays a pivotal role in modernizing and increasing access to clinical trials for participants.
Decentralized Clinical Trial Solutions
Allucent has extensive experience across multiple aspects of decentralized trials including both fully virtual and hybrid approaches. Hybrid and Decentralized Clinical Trials (DCTs) offer great potential to rethink and refresh the traditional clinical trial models, enabling patients to interact with clinical researchers away from the traditional site setting.
To maximize the benefits of DCT solutions, DCT elements should be incorporated during the protocol design process to ensure seamless implementation and operational success. When successfully executed, DCTs can reduce the patient burden of participation, improve accessibility, and increase access to a wider geographically dispersed and diverse patient population.
Advantages of Decentralized Clinical Trials
- Expand Patient Access
- Accelerate Patient Recruitment
- Improve Patient Engagement & Retention
- Capture Higher-Quality Clinical Data
- Enhance Patient Safety & Experience
- Increase Operational Efficiency
- Enhance Trial Continuity
- Reduce Costs & Environmental Impact
Allucent Decentralized Ecosystem
Electronic Clinical Outcome Assessments (eCOA) simplify the collection of patient, clinician, and caregiver data while improving participant convenience, compliance, and data quality. Allucent delivers integrated, secure eCOA solutions that provide reliable, real-time data to support efficient decentralized clinical trial execution.
Telehealth and home health services enable clinical trials to reach participants wherever they are, reducing the burden of participation while maintaining the human connection between patients and care teams. Through trusted strategic partners, we deliver virtual visits and in-home clinical services that make participation easier for patients and their families, improve access to care, and support long-term engagement throughout the study.
Thanks to state-of-the-art technology, data capture is streamlined across sites, remote settings, telehealth visits, and connected devices. Real-time clinical trial performance data, together with predictive insights into enrollment, retention, and study completion, are delivered through an integrated dashboard to support faster, more informed decision-making.
Wearables and medical devices further extend this connected ecosystem by enabling participants to capture data seamlessly from home. Easy-to-use technologies improve the participant experience while supporting robust, high-quality data collection for exploratory, secondary, and even primary endpoints.
Compliant eConsent and integrated patient education provide a secure, convenient, and engaging participant experience. Participants can electronically review and sign consent forms, access study materials and instructional videos, and receive guidance for at-home activities such as IMP administration and sample collection. Integrated eDiary tracking supports protocol compliance while meeting local regulatory requirements.
Manage patient interactions throughout the trial through direct notifications and reminders ensuring participants are well-informed, engaged, and compliant with the trial requirements, which in turn supports the trial’s success. By raising site notifications based upon correct triggers, sites are directed to support those participants that require guidance and ensure all data is collected as required for the trial.
We partner with trusted providers to deliver IMP, test kits, and other clinical supplies directly to participants homes. Direct-to-patient logistics reduce the need for site visits, improve participant convenience, support protocol adherence, and help keep studies on track through coordinated communication with both participants and sites.
Other Areas of Expertise
Additional Resources
Case Studies
Successfully Overcoming Recruitment Challenges and Multiple Protocol Changes in a Complex Phase II Colon Cancer Study
Learn More
Blogs
Sifting Through Rarity: Advanced Patient Screening for Rare Disease Trials
Learn More
Blogs
Fostering Inclusion and Diversity in Clinical Trials
Learn More